Patrik Midlöv

Prof. Patrik Midlöv

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2014 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
VMVeronica Milos
Veronica Milos
ÅBÅsa Bondesson
Åsa Bondesson
MMMartina Magnusson
Martina Magnusson
UJUlf Jakobsson
Ulf Jakobsson
LWLars Ove Tommy Westerlund
Lars Ove Tommy Westerlund
PMPatrik Midlöv
Patrik Midlöv
Falls are the most common cause of injuries and hospital admissions in the elderly. The Swedish National Board of Health and Welfare has created a list of drugs considered to increase the fall risk (FRIDs) and drugs that might cause/worsen orthostatism (ODs). This cross-sectional study was aimed to assess FRIDs and their correlation with falls in a sample of 369 community-dwelling and nursing home patients aged ≥75 years and who were using a multi-dose drug dispensing system.

12 February 2011 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
LHLina M. Hellström
Lina M. Hellström
ÅBÅsa Bondesson
Åsa Bondesson
PHPeter Höglund
Peter Höglund
PMPatrik Midlöv
Patrik Midlöv
LHLydia Holmdahl
Lydia Holmdahl
TETommy Eriksson
Tommy Eriksson

11 January 2011 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
Sara ModigSara Modig
Sara Modig
CLChristina Lannering
Christina Lannering
CÖCarl Johan Östgren
Carl Johan Östgren
SMSigvard Mölstad
Sigvard Mölstad
PMPatrik Midlöv
Patrik Midlöv
Renal function decreases with age. Dosage adjustment according to renal function is indicated for many drugs, in order to avoid adverse reactions of medications and/or aggravation of renal impairment. There are several ways to assess renal function in the elderly, but no way is ideal. The aim of the study was to explore renal function in elderly subjects in nursing homes and the use of pharmaceuticals that may be harmful to patients with renal impairment.

14 February 2013 in Drugs & Aging
Verified
Journal Article
Closed access
PDF file
VMVeronica Milos
Veronica Milos
EREva Rekman
Eva Rekman
ÅBÅsa Bondesson
Åsa Bondesson
TETommy Eriksson
Tommy Eriksson
UJUlf Jakobsson
Ulf Jakobsson
PMPatrik Midlöv
Patrik Midlöv

26 June 2009 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
ABAnna Bergkvist
Anna Bergkvist
PMPatrik Midlöv
Patrik Midlöv
PHPeter Höglund
Peter Höglund
LLLisa Larsson
Lisa Larsson
ÅBÅsa Bondesson
Åsa Bondesson
TETommy Eriksson
Tommy Eriksson

15 October 2014 in Scandinavian Journal of Primary Health Care
Verified
Journal Article
Open access
CLCecilia Lenander
Cecilia Lenander
BEBirgitta Elfsson
Birgitta Elfsson
BDBirgitta Danielsson
Birgitta Danielsson
PMPatrik Midlöv
Patrik Midlöv
JHJan Hasselström
Jan Hasselström
To determine whether a pharmacist-led medications review in primary care reduces the number of drugs and the number of drug-related problems. Prospective randomized controlled trial. Liljeholmen Primary Care Centre, Stockholm, Sweden. 209 patients aged ≥ 65 years with five or more different medications. Intervention. Patients answered a questionnaire regarding medications. The pharmacist reviewed all medications (prescription, non-prescription, and herbal) regarding recommendations and renal impairment, giving advice to patients and GPs. Each patient met the pharmacist before seeing their GP. Control patients received their usual care. Drug-related problems and number of drugs. Secondary outcomes included health care utilization and self-rated health during 12 months of follow-up. No significant difference was seen when comparing change in drug-related problems between the groups. However, a significant decrease in drug-related problems was observed in the intervention group (from 1.73 per patient at baseline to 1.31 at follow-up, p < 0.05). The change in number of drugs was more pronounced in the intervention group (p < 0.046). Intervention group patients were not admitted to hospital on fewer occasions or for fewer days, and there was no significant difference between the two groups regarding utilization of primary care during follow-up. Self-rated health remained unchanged in the intervention group, whereas a drop (p < 0.02) was reported in the control group. This resulted in a significant difference in change in self-rated health between the groups (p < 0.047). The addition of a skilled pharmacist to the primary care team may contribute to reductions in numbers of drugs and maintenance of self-rated health in elderly patients with polypharmacy.